Systems Pharmacogenomic Landscape of Drug Similarities from LINCS data: Drug Association Networks

Aliyu Musa, Shailesh Tripathi, Matthias Dehmer, Olli Yli-Harja, Stuart A. Kauffman, Frank Emmert-Streib

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)


Modern research in the biomedical sciences is data-driven utilizing high-throughput technologies to generate big genomic data. The Library of Integrated Network-based Cellular Signatures (LINCS) is an example for a large-scale genomic data repository providing hundred thousands of high-dimensional gene expression measurements for thousands of drugs and dozens of cell lines. However, the remaining challenge is how to use these data effectively for pharmacogenomics. In this paper, we use LINCS data to construct drug association networks (DANs) representing the relationships between drugs. By using the Anatomical Therapeutic Chemical (ATC) classification of drugs we demonstrate that the DANs represent a systems pharmacogenomic landscape of drugs summarizing the entire LINCS repository on a genomic scale meaningfully. Here we identify the modules of the DANs as therapeutic attractors of the ATC drug classes.

Original languageEnglish
Article number7849
Pages (from-to)7849
JournalScientific Reports
Issue number1
Publication statusPublished - 1 Dec 2019


  • Data Science/methods
  • Databases, Genetic/statistics & numerical data
  • Databases, Pharmaceutical/statistics & numerical data
  • Gene Expression Profiling
  • Gene Regulatory Networks
  • Humans
  • Pharmacogenetics/methods
  • Pharmacological Phenomena/genetics
  • Systems Biology/methods


Dive into the research topics of 'Systems Pharmacogenomic Landscape of Drug Similarities from LINCS data: Drug Association Networks'. Together they form a unique fingerprint.

Cite this